MULTI-SPECIALTY HOSPITALS -

May 25,2019

The Listing Department Corporate Service Department

National Stock Exchange of India Ltd BSE Limited

Mumbai 400 051. Mumbai 400 001.

Scrip Code : SHALBY Scrip Code: 540797

Sub: lnvestor Presentation for the Fourth Quarter and year ended 31" March 2019, disclosure

under Regulation 30 of SEBl (Listing Obligations and Disclosure Requirements),

Regulations, 2015 ("the SEBI LODR")

Dear Sir / Madam,

We are submitting herewith lnvestor Presentation on financial & operational performance of

the Company for the Fourth Quarter and year ended 31" March 2019, which is also being made

available on our website.

We request to take the same on your records and disseminate the same to the members.

Thanking you,

Yours sincerely,

For Shalby Limited

Jayesh Patel

Company Secretary & Compliance Officer

Encl.: as above

Shalby Limited Regd. Off. : Opp. Karnavati Club, S G Road, Ahrnedabad - 380015 (India) Tel. No. : (079) 40203000 I Fax : (079) 40203109 1 www.shalbv.ore: I [email protected] Regd. No. : 061000596 1 CIN : L85110G12004PLC044667 Vapi - lndore - labalpur - Mohali - Naroda (Ahrnedabad) I

No representation or warranty, express or implied is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of such information or opinions contained herein. The information contained in this presentation is only current as of its date. Certain statements made in this presentation may not be based on historical information or facts and may be “forward looking statements”, including those relating to the Company’s general business plans and strategy, its future financial condition and growth prospects, and future developments in its industry and its competitive and regulatory environment. Actual results may differ materially from these forward-looking statements due to a number of factors, including future changes or developments in the Company’s business, its competitive environment and political, economic, legal and social conditions in India. This communication is for general information purpose only, without regard to specific objectives, financial situations and needs of any particular person. This presentation does not constitute an offer or invitation to purchase or subscribe for any shares in the Company and neither any part of it shall form the basis of or be relied upon in connection with any contract or commitment whatsoever. The Company may alter, modify or otherwise change in any manner the content of this presentation, without obligation to notify any person of such revision or changes. This presentation can not be copied and/or disseminated in any manner.

2 …because passion drives perfection… …and perfection drives performance

“

3 1 Shalby Limited A proxy for growth in the Indian Healthcare space

4 Current Scale of Operations

11 Hospitals 55% Operating bed to total bed capacity

2,012* Total Bed Capacity 47% Bed Occupancy (based on census beds)

1,102** Operational beds 31% 12 year CAGR Revenue

Census Beds 887 36% 12 year CAGR EBITDA 165 Non Census Beds

500+ Doctors & 2600+ Support Staff

Double-digit return ratios against industry trend of single-digit

Consistently superior ROCE of mature hospitals **The operational bed count of 1,102 considers 50 operational beds at5 Zynova- * Maximum number of beds according to structure of the hospital Shalby Hospital, Mumbai, for which no other operational parameters are tracked Promoter

Qualifications Achievements Academic Qualifications: • Over two and a half decades of professional work experience • MBBS across UK, USA and India. Serving as Director, Department of Knee • MS (Orthopaedics) Replacement at Shalby Hospitals since 1993

Professional Qualifications • Dr. Shah innovated zero ‘0’ Technique in 2011 and was awarded the • AO Basic Course Double Helical Award 2017, for the innovation (London)  Reduction of surgery time: 2.5 hours to 22 minutes • F.A.O.A.A (Switzerland)  Reduction in patient stay: 15 days to 3 days • F.A.I.S.F (Germany)  Drastic fall in infection rates due to minimum incision

• Invented the OS Needle, which is thick bore reverse cutting needle Dr. Vikram Shah used in attaching soft tissues to the bone. Before the invention of Chairman & Managing the Needle, surgeons had to use complicated soft tissue Director procedures that had a very high failure rate. The needle can be attached with commonly available vicryl thread

• President of Indian Society of Hip & Knee Surgeons (ISHKS) for the year 2010-11

• Part of joint international faculty for development of new joints by Zimmer Inc., USA

• Receiver of several awards and accolades by reputed organizations

6 Our Journey so far…

Started professional Operationalized First Commissioned Shalby practice with a 6-bed Multispecialty Hospital of the [Bed Capacity: 233] facility group Shalby SG Commissioned Shalby [Bed Capacity: 201] [Bed Capacity: 243]

1994 2004 2007 2011 2015 2017

6 27 228 674 1150 2012

Revenue growth – 100 Acquired Shalby Vapi Bed capacity grown 10 times times in first 10 years [Bed Capacity: 146] in 10 years – to 2012 beds Incorporation of Company Acquired Krishna Shalby Commissioned: [Bed Capacity: 220] Shalby [Bed Capacity: 237] Shalby Naroda [Bed Capacity: 267] Shalby [Bed Capacity: 243] Shalby Mohali [Bed Capacity: 145]*

7 *Operationalized in Q1 FY 19 Reach and Presence - Hospitals

Network of Hospitals in India with bed capacity

Mohali – 145 beds Jabalpur – 233 beds

Indore – 243 beds Jaipur – 237 beds

Ahmedabad SG – 201 beds Krishna – 220 beds Vijay – 27 beds Mumbai – 50 beds Naroda – 267 beds (Ghatkopar)

Vapi – 146 beds Surat – 243 beds Mumbai – 175 beds (Santacruz) Nashik – 113 beds Mumbai – Additional 100 beds (Ghatkopar) Hospital (operational) Hospital (upcoming)

Has a total bed capacity of 2,012 beds across 11 multi-specialty hospitals 8 Reach and Presence - OPD

Network of Outpatient Clinics in India International Footprint Presence in Africa

Kenya

Tanzania

Ethiopia Sudan (1) Addis Ababa (1) Sudan Eldoret Kisumu Nairobi (1) Rwanda (1) Nairobi (1) Rwanda Dar es Salaam (2)

Outpatient clinics

OPD Clinics

Has a network of 40 patient outreach centres in India International footprint consists of 6 outpatient clinics in Africa 9 Expansion Plans in Progress

Investment Plans for Upcoming facilities

•Bed Capacity 113 Nashik •Capex – Rs 25 Crore

Mumbai •Bed Capacity 175 [Santa Cruz] •Capex – Rs 150 Crore

•Current bed capacity 50. Mumbai •Addition 100 beds [Ghatkopar] •Capex – Nil

Total capex planned – Rs. 175 Crore for addition of 388 beds 10 2 Our Unique Business Model is the key to our outperformance

11 Our Business Model – features Optimising Capex and Opex

• Lowest Capex and Opex per bed due Optimize capex Operational planning with Efficiency due to optimal use of real-estate Inhouse projects to team better capex • Equipment planning and utilities planning planning • In-house planning teams • Focus on surgeries with higher ARPOB, better margins and return ratios EBITDA upwards Cost per bed ~ of 20% which is • Centralised procurement Rs. 3.5 millions higher than industry average • Gradual ramp-up of bed capacity • Fully owned or O&M on revenue sharing (no fixed rentals, no security Better Leveraging deposit or MG) Utilities utilization economies of planning Low consumable of space [and scale through to optimize cost expensive real centralized capex estate] procurement

12 Typical concept of 200 (±20%) bed capacity set-up

Facilities 10-15 kms away

Local and Natural Footfalls from 4- 5 kms radius helps to fill up ~50% beds

Balance ~50% – patients come in the name of doctors reducing thereby dependency on star doctors thus controlling doctor payout %

13 Our Business Models…

Fully Owned

No fixed Efficiency is rental paramount Unique revenue No security Operate and sharing deposit Hospital Manage Management model [Revenue Contracts Sharing] No minimum guarantee

14 Role of OPDs for expansion

Simultaneously hire local doctors Patients visit our and train them at clinics across who Punjab India and abroad conduct OPDs in and around So we can start We analyze that city the facility with patient trends and Rajasthan low branding accordingly decide budget but high where to expand brand recall Madhya Pradesh Ahmedabad

Set-up Maharashtra outpatient clinics where we have a strong brand recall

Operating such Outpatient clinics for 15 years now

15 3 Case for Expansion

16 The Opportunity Set

Population and Population Growth Rate of India Spilt of Indian Healthcare Industry by Segments (Historical and Expected) Total market size (2016): INR 9.2 trillion

CAGR (2014-2020) 4% 100%= 9% 1.27 billion 1.29 billion 1.32 billion 1.35 billion 0.9% 13%

54+ years 100% 2.6% 6% 35-54 years 80% 68% 1.6%

20-34 years 60% 0.7% 0-19 years 40% -0.04% 20% Healthcare Delivery-Hospitals Diagnostics 0% 2014(E) 2016(E) 2018(E) 2020(E) Pharma Medical Devices Health Insurance

17

Source: National Commission Population Frost & Sullivan analysis. The Opportunity Size

Indian Healthcare Delivery Industry size (2015-2020) Spilt of Public and Private Hospitals in India (INR in Trillion)

11.7

10 30% 8.5 70% 7.3 6.2 5.4

Private Corporate Hospitals account to less Public Hospitals Private Hospitals than 10% of the 2015 2016(E) 2017(E) 2018(E) 2019(E) 2020(E) total Private Hospitals

18

Source: Frost & Sullivan analysis. Recent transformation

• Private sector investment has been increasing due to change in mind-set and better returns on investment • Healthcare businesses can also be profitable as long the costs are affordable • The advent of information technology has given a fillip to the healthcare business making it both controllable and scalable • Rising aspirational middle-class today is not averse to paying for quality healthcare services • Impact of health insurance, government schemes and emergence of medical tourism - key drivers of positive change • Healthcare today in India is evolving to be a larger consumer story than ever before

19 Case study - the Cardiac growth story in India

2014 ~ 2,00,000 surgeries and Facilities 10-15 kms away 8,00,000 CAGR – 29% in 30 years. angioplasties Currently growing @ 2-3%

2004 ~ 50,000 surgeries

1994 ~5000 Wide procedure penetration – surgeries to Tier 2 and 3 cities

1984 ~500 surgeries

20

Source: Industry reports Knee Replacement - the big opportunity

2017 ~1,75,000 surgeries

2010 Last year, In ~54,000 United States surgeries ~0.8 mn knee replacements in a population of 2000 ~300 mn ~6000 India has a surgeries similar affording population. Hence, direct potential to grow to 8 lacs Knee 1994 Asian replacements ~300 population 15 Hence huge surgeries times more potential for prone to growth based Arthritis of knee than their on incidence western counter rates parts Surgery Count CAGR @32% in 23 years 21

Source: Industry reports Growth Drivers for Shalby

Pioneer in Joint Replacements in the country, best positioned to capitalize on it

Continue to gain Opportunities traction within within Homecare and Huge scope for Neurology organic growth and operating leverage

Increasing focus on quaternary treatments like Cardiac Sciences, organ and Critical Care transplants such as Liver, Heart, Lungs and Kidney 22 Conducive Government Policies Despite Challenges

Swastha Bharat, Smriddha Bharat. Demographic dividend realization impossible without proper healthcare Rashtriya Samaj Beema Yojana: 100 mln families will get Rs 500,000 per year for their families to cover secondary and tertiary hospital expenses

100% depreciation on capex incurred, MAT credit can be availed for 15 years, all Wide procedurehealthcare penetrationeducation and – training services to Tier exempted2 and 3 citiesfrom GST

State Policies include capital subsidy on purchase of medical equipment, capital investment subsidy on construction of tertiary-care hospitals and interest subvention, along with several other benefit

23 Track record

24 Best in class economic returns

1200 40%

5020 4706 250% 1000 925 30% 26% 25% 25% 24% 907 149% 3,923 4020 150% 20% 778 800 16% 20% 24% 20% 3,305 21% 55% 660 687 19% 38% 26% 36% 2,927 3020 29% 2,776 50% 14% 14% 579 2,617 600 11% 10% 2,298 482 19% 20% 439 14% 6% 5% 13% 2020 1,685 -50% 400 0% 1,332 262 1,030 200 142 -10% 1020 745 -150% 77 107 482 22 194 0 -20% 20 -250% FY07FY08FY09FY10FY11FY12FY13FY14FY15FY16FY17FY18FY19 FY07 FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 Revenue (in Mn) Growth (%) EBITDA (in Mn) Margin (%)

Revenue CAGR growth 31% in last 12 years EBITDA CAGR growth 36% in last 12 years

25 Best in class economic returns

RoCE% RoE%

7798 8,553 8408 28% 31% 26% 7,615 88% 20% 66% 17% 15% 13% 51% 36% 9% 11% 26% 20% 22% 6% 15% 14% 13% 4% 10% 7% 2% 5,488 4,153 2,508 2,109 2,544 1,814 1,817 1,487 1,207 844 1,096 852 203 259 345 481 239 181 163 314

FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 Capital Employed (Rs in Mn) RoCE(%) Net Worth (Rs in Mn) RoE(%)

26 Performance Q4FY19

27 Key Achievements of the Quarter

Cancer Surgeon team at Shalby successfully Gall Bladder Cancer Blockage in performed Esophageal in an 84 year old Vein supplying blood Cancer (Cancer of the patient cured at to Liver, removed in Food Pipe) through Shalby through a rare surgery at Keyhole Surgery surgeryWide procedure penetration Shalby Hospitals avoiding the need for and treatment– to Tier 2 and 3 cities Open Chest Surgery

28 IP and OP Count (Quarterly Trend)

29 Surgeries Count (Quarterly Trend)

30 Surgeries Count (Quarterly Trend)

Arthroplasty Vs Others

47% 48% 50% 51% 49% 53% 50% 54% 58% 55% 56% 55%

53% 52% 50% 49% 51% 47% 50% 46% 42% 45% 44% 45%

Q1FY17 Q2FY17 Q3FY17 Q4FY17 Q1FY18 Q2FY18 Q3FY18 Q4FY18 Q1FY19 Q2FY19 Q3FY19 Q4FY19 Arthroplasty Others

31 Performance Synopsis Q4 FY19

Quarter Ended Quarter Ended Particulars % of Revenue % of Revenue Growth 31-03-19 31-03-18

Total Revenue (INR in million) 1153.9 1110.4 4%

Total EBITDA (INR in million) 169.8 14.7% 172.1 15.5% (1%)

Bed Capacity (Nos.) 2012 2012 N.A

Operational Beds (Nos.) 1102 1102 N.A

Average Length of Stay 2.45 3.6 N.A

Occupancy (Beds) 417 396 5%

In-Patient Count (Nos.) 15316* 9998 53%

Out patient Count (Nos.) 77140 64189 20%

Surgeries Count 4893 4802 2%

ARPOB ( In Rs.) 30760 30625 0.4%

* Increase in IP Count is witnessed due to drastic increase of day care procedures like Radiation therapy, Dialysis etc in Units having < 2 years of Maturity Profile 32 Note: The operational bed count of 1,102 considers 50 operational beds at Zynova-Shalby Hospital, Mumbai, for which no other operational parameters are tracked Financial Highlights Q4FY19 Standalone

(INR in million) Quarter Ended Quarter Ended Particulars % of Revenue % of Revenue Growth 31-03-19 31-03-18 Revenue from Operations 1126.8 1083.7 4.0% Other Income 27.1 26.7 1.6% Total Income 1153.9 1110.4 3.9% Expenses Materials & Consumables 316.5 27.4% 264.4 23.8% Fees to Doctors and Consultants 328.7 28.5% 300.1 27.0% Other Operative Expenses 35.3 3.1% 78.3 7.1% Employee Costs 217.1 18.8% 139.1 12.5% Administrative Expenses 69.5 6.0% 122.8 11.1% Advt. & Promotion 16.9 1.5% 33.5 3.0% Total Operational Expenses 984.1 85.3% 938.3 84.5% EBITDA 169.8 14.7% 172.1 15.5% (1.3%) Finance Cost 22.1 (3.1) Depreciation & Amortization Expense 78.8 64.1 Profit before tax (PBT) 68.9 111.1 (38.0%) Tax Expense 35.0 (71.8) Profit after tax (PAT) 33.9 2.9% 182.9 16.5% (81.5%)

Company is falling under MAT for FY19 as well as FY18 and taxed @ 21.54% 33 Financial Parameters Q4 FY19

1153.9 172.1 182.86

1110.4 169.8

33.9

Q4 FY19 Q4 FY18 Q4 FY19 Q4 FY18 Q4 FY19 Q4 FY18 Total Revenue ( In Rs. Mn.) EBITDA ( In Rs. Mn.) PAT ( In Rs. Mn.)

34 ARPOB and ALOS (Quarterly)

30900 30760 4 30700 3.6 30625 3.5 30500 3 30300

30100 2.5 2.4 29900 2 29700 1.5 29500

29300 1 Q4 FY19 Q4 FY18 ARPOB ( In Rs / day) ALOS

* Decrease in ALOS is witnessed due to drastic increase of day care procedures like Radiation therapy, Dialysis etc in Units having < 2 years of Maturity Profile 35 Revenue Mix Q4FY19

Specialty Mix Payer Profile

9% 5% 4% 5% 22% 7% 43%

51% 9%

11% 22% 12%

Self Pay Corporate Government TPA Corporate Private Arthroplasty Critical Care & General Medicine Cardiac Science Oncology Other Ortho Neurology Nephrology Others

36 Surgery Count and Cost Structure Q4FY19 2% 6%

21% 19%

3%

3% 45% 4% 29%

4%

6% 27% 6% 11%

Arthroplasty Orthopaedic Q4 FY19 General Surgery Nephrology Advertising & Promotion Administrative Expenses Gynecology & IVF Cosmetic & Plastic Surgery Employee Cost Other Operative Expenses

Oncology Others Fees to Doctors and Consultants Materials & Consumables 37 Bed Count Split(Quarterly)

2,012 2,012

1,102 1,102

396 417

Q4 FY18 Q4 FY19 Bed Capacity Operational Occupied

38 Maturity Profile – Q4FY19

Avg. Operational Non- Non-Census Total Bed Maturity Profile Occupied Census Beds Beds Operational Beds Capacity Beds Beds

4 years + (SG; Vijay; 159 325 57 382 212 594 Krishna; Vapi)

2-4 years (Jabalpur, 124 309 52 361 115 476 Indore)

< 2 years (Jaipur; Naroda; 134 253 309 583 892 Surat; Mohali) 56

Total 417 887 165 1,102* 910 2,012

Note: The operational bed count of 1,102 considers 50 operational beds at Zynova-Shalby Hospital, Mumbai, for which no other operational parameters 39 are tracked Maturity Profile – Q4 FY19 vs Q4 FY18 – Operational Parameters

Q4 FY 19 Q4 FY 18

Maturity Profile IP Count OP Count Surgery Count Maturity Profile IP Count OP Count Surgery Count

4 years + 4 years + (SG; Vijay; 4005 29507 2807 (SG; Vijay; 4294 30140 2963 Krishna; Vapi) Krishna; Vapi)

2-4 years 2-4 years 22736 937 20575 1039 (Jabalpur, Indore) 3085 (Jabalpur, Indore) 3303

< 2 years < 2 years (Jaipur; Naroda; (Jaipur; Naroda; 8226 24897 1,149 2401 13474 800 Surat; Mohali) Surat; Mohali)

Total 15316 77140 4,893 Total 9998 64189 4802 40 Maturity Profile – Q4FY19 – with Revenue mix

Maturity % of Total Non Arthroplasty ARPOB(Rs) ALOS(Days) EBITDA % Profile Revenue Arthroplasty

4 years + (SG; Vijay; 51% 30% 21% 40966 3.57 27% Krishna; Vapi)

2-4 years (Jabalpur, 20% 4% 16% 20460 3.63 3.8% Indore)

< 2 years (Jaipur; Naroda; Surat; 29% 9% 20% 27171 1.46 1.3% Mohali)

Total 100% 43% 57% 30760 2.45 14.7% 41 Track record (Yearly Trend)

42 IP and OP Count (Yearly Trend)

OP Count

296197

222,970

166,519 152,921 125,981 128,821 110,919

55,143 33,285 43,409 7,632 19,295

FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19

43 Surgeries Count (Yearly Trend)

Surgeries Count: Arthroplasty vs Others

11148 9,059 6,280 7,399 6,361 5,586 3,827 2,628 2,014 8,006 8,495 8,760 371 6,856 7,330 7,816 154 5,166 6,019 66 3,576 4,442 1,900 2,596

FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19

Arthroplasty Others

44 Surgeries Count (Yearly Trend) Arthroplasty Vs Others

3% 6% 9%

31% 34% 39% 45% 46% 44% 49% 52% 56%

97% 94% 91%

69% 66% 61% 55% 54% 56% 51% 48% 44%

FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 Arthroplasty Others

45 Performance Synopsis FY19

Year Ended Year Ended Particulars % of Revenue % of Revenue Growth 31-03-19 31-03-18

Total Revenue (INR in million) 4708.5 3942.35 19.4%

Total EBITDA (INR in million) 908.7 19.3% 930.67 23.6% (2.4%)

Bed Capacity (Nos.) 2012 2012 N.A

Operational Beds (Nos.) 1102 1102 N.A

Average Length of Stay 2.7 3.7 N.A

Occupancy (Beds) 413 335 23.3%

In-Patient Count (Nos.) 55985 * 32967 69.8%

Out patient Count (Nos.) 296,197 222,970 32.8%

Surgeries Count 19908 17,554 13.4%

ARPOB ( In Rs.) 31235 31564 (1.0%)

* Increase in IP Count is witnessed due to drastic increase of day care procedures like Radiation therapy, Dialysis etc in Units having < 2 years of Maturity Profile

Note: The operational bed count of 1102 considers 50 operational beds at Zynova-Shalby Hospital, Mumbai, for which no other operational parameters are tracked 46 Financial Highlights FY19 Standalone

(INR in million) Year ended Year ended Particulars % of Revenue % of Revenue Growth 31-03-19 31-03-18 Revenue from Operations 4611.1 3855.2 19.6% Other Income 97.5 87.1 11.9% Total Income 4708.5 3942.4 19.4% Expenses Materials & Consumables 1215.4 25.8% 947.7 24.0% Fees to Doctors and Consultants 1243.1 26.4% 898.1 22.8% Other Operative Expenses 155.6 3.3% 326.7 8.3% Employee Costs 851.4 18.1% 447.9 11.4% Administrative Expenses 265.6 5.6% 319.6 8.1% Advt. & Promotion 68.8 1.5% 71.7 1.8% Total Operational Expenses 3799.8 80.7% 3011.7 76.4% EBITDA 908.7 19.3% 930.7 23.6% (2.4%) Finance Cost 71.4 121.3 Depreciation & Amortization Expense 330.0 224.3 Profit before tax (PBT) 507.3 585.01 (13.3%) Tax Expense 186.2 144.9 Profit after tax (PAT) 321.0 6.8% 440.2 11.2% (27.1%)

Company is falling under MAT for FY19 as well as FY18 and taxed @ 21.54% 47 Financial Parameters FY19

930.7 440.2 4708.5 908.7 321

3942.4

FY19 FY18 FY19 FY18 FY19 FY18 Total Revenue ( In Rs. Mn.) Operational Ebitda ( In Rs. Mn.) PAT ( In Rs. Mn.)

48 ARPOB and ALOS (Yearly)

4

32000 3.7 3.5 31564 31500 31235 3

31000 2.7 2.5

30500 2

30000 1.5

29500 1 FY19 FY18 ARPOB ( In Rs / day) ALOS

* Decrease in ALOS is witnessed due to drastic increase of day care procedures like Radiation therapy, Dialysis etc in Units having < 2 years of Maturity Profile 49 Revenue Mix FY19

Specialty Mix Payer Profile

10% 5% 4% 15% 4% 7% 45%

20% 8% 60%

11% 11%

Self Pay Corporate Government TPA Corporate Private Arthroplasty Critical Care & General Medicine Cardiac Science Oncology Other Ortho Neurology Nephrology Others

50 Surgery Count and Cost Structure FY19 Cost Structure 2% 6% 20% 18%

3% 3% 44% 3%

5% 26%

6%

6% 13% 26%

Arthroplasty Orthopaedic General Surgery Nephrology FY19 Gynecology & IVF Cosmetic & Plastic Surgery Materials & Consumables Fees to Doctors and Consultants Oncology Others Other Operative Expenses Employee Cost Administrative Expenses Advertising & Promotion

51 Bed Count Split(Yearly)

2,012 2,012

1,102 1,102

413 335

FY18 FY19 Bed Capacity Operational Occupied

52 Maturity Profile – FY19 – with Revenue mix

Maturity % of Total Non Arthroplasty ARPOB(Rs) ALOS(Days) EBITDA % Profile Revenue Arthroplasty

4 years + (SG; Vijay; 51% 31% 20% 42107 3.32 30% Krishna; Vapi)

2-4 years (Jabalpur, 22% 4% 18% 20735 3.64 9.0% Indore)

< 2 years (Jaipur; Naroda; Surat; 28% 10% 18% 29127 1.76 7.3% Mohali)

Total 100% 45% 55% 31235 2.69 19.3% 53 Maturity Profile – Operational Parameters FY 19 FY 18

Maturity Profile IP Count OP Count Surgery Count Maturity Profile IP Count OP Count Surgery Count

4 years + 4 years + (SG; Vijay; 17019 115093 10792 (SG; Vijay; 15,989 110710 12,026 Krishna; Vapi) Krishna; Vapi)

2-4 years 13640 91021 4193 2-4 years 11,725 74,357 3,317 (Jabalpur, Indore) (Jabalpur, Indore)

< 2 years < 2 years (Jaipur; Naroda; (Jaipur; Naroda; Surat; Mohali) 25326 90083 4923 Surat; Mohali) 5,253 37,903 2,211

Total 55985 296197 19908 Total 32967 222970 17554 Maturity Profile – FY19 – with Revenue mix

Maturity % of Total Non Arthroplasty ARPOB(Rs) ALOS(Days) EBITDA % Profile Revenue Arthroplasty

4 years + (SG; Vijay; 51% 30% 21% 42107 3.32 30% Krishna; Vapi)

2-4 years (Jabalpur, 22% 4% 18% 20735 3.64 9.0% Indore)

< 2 years (Jaipur; Naroda; Surat; 28% 10% 18% 29127 1.76 7.3% Mohali)

Total 100% 44% 56% 31235 2.69 19.3% 55 Shareholding Pattern

0.31% Shareholding as on 31st March 2019 0.55% 0.03% Promoter Individuals 0.91% 0.30% 0.12% Resident Individuals 0.94% 0.05% Foreign Portfolio - Corp 4.85%

5.54% Bodies Corporates

Employee Trusts 7.00% Alternative Investment Fund

H U F

Non Resident Indians

Mutual Funds

Non Resident Indian Non Repatriable 79.41% Banks

Others

56 Dividend for FY 2018-19

We take pleasure to inform that Company has recommended dividend of 5% . Our Strengths and Differentiators

Strong brand, Increasing focus Experienced global Optimized on Quaternary promoters with leadership in Business Model treatments such hands-on Joint now being as Oncology and involvement Replacement replicated Organ transplants

Even after the Strong emphasis Leadership and Unleveraged IPO promoter on governance succession plan Balance Sheet holding is ~80% and compliance in place

58 Detailed Information

For more detailed information please click on the link below: • Q4FY19 result • Q3FY19 result • Q2FY19 result • Q1FY19 result • Monitoring Agency Report for IPO proceeds • FY19 result

59 Thank you

SHALBY LIMITED Regd Off: Opp. Karnavati Club, S.G. Road, Ahmedabad – 380015, Gujarat, India. Phone: 079 4020 3000 Fax: +91 79 4020 3120 | Website: www.shalby.org | CIN: L85110GJ2004PLC044667

Script code: BSE: 540797 | NSE: SHALBY